Goldman Sachs analyst Emily Chieng maintains Arconic (NYSE:ARNC) with a Neutral and lowers the price target from $35 to $22.
Moderna Inks Deal For Updated COVID Shots For Low Income Countries
Moderna Inc (NASDAQ:MRNA) and Gavi, the Vaccine Alliance, agreed to cancel the remaining pending orders under the current COVID-19 vaccine supply…